Cas:27906-91-8 (2-Phenylethyl)propylamine manufacturer & supplier

We serve Chemical Name:(2-Phenylethyl)propylamine CAS:27906-91-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(2-Phenylethyl)propylamine

Chemical Name:(2-Phenylethyl)propylamine
CAS.NO:27906-91-8
Synonyms:N-(2-phenylethyl)propan-1-amine
Molecular Formula:C11H17N
Molecular Weight:163.25900
HS Code:2921199090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:241.4ºC at 760 mmHg
Density:0.904g/cm3
Index of Refraction:1.502
PSA:12.03000
Exact Mass:163.13600
LogP:2.61960

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like N-(2-phenylethyl)propan-1-amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-(2-phenylethyl)propan-1-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-(2-phenylethyl)propan-1-amine Use and application,N-(2-phenylethyl)propan-1-amine technical grade,usp/ep/jp grade.


Related News: For example, there are concerns that PFAS’ effect on the thyroid could lead to thyroid cancer, van Gerwen said. (2-Phenylethyl)propylamine manufacturer The FDA has granted so-called accelerated approval in more than 250 instances since 1992, mainly for rare diseases or small patient populations that have had no effective treatments available to them. In these cases, the agency requires that drugmakers conduct additional clinical trials to prove their therapy works, or face withdrawal from the market. (2-Phenylethyl)propylamine supplier The number of Americans living with Alzheimer’s is expected to more than double to around 13 million by 2050, according to the Alzheimer’s Association. (2-Phenylethyl)propylamine vendor ICIG is a privately owned industrial holding company focusing on mid-sized chemicals and pharmaceutical businesses. (2-Phenylethyl)propylamine factory The number of Americans living with Alzheimer’s is expected to more than double to around 13 million by 2050, according to the Alzheimer’s Association.